TradeLink Capital LLC Purchases New Shares in Clover Health Investments, Corp. (NASDAQ:CLOV)

TradeLink Capital LLC acquired a new stake in Clover Health Investments, Corp. (NASDAQ:CLOV) in the 1st quarter, according to the company in its most recent filing with the SEC. The firm acquired 30,700 shares of the company’s stock, valued at approximately $110,000.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Graham Capital Management L.P. purchased a new position in Clover Health Investments in the 4th quarter valued at approximately $889,000. Marshall Wace LLP grew its position in shares of Clover Health Investments by 167.6% in the fourth quarter. Marshall Wace LLP now owns 3,769,765 shares of the company’s stock valued at $11,875,000 after purchasing an additional 2,360,902 shares in the last quarter. Barclays PLC lifted its holdings in Clover Health Investments by 336.5% during the 4th quarter. Barclays PLC now owns 461,692 shares of the company’s stock worth $1,454,000 after purchasing an additional 355,926 shares in the last quarter. JPMorgan Chase & Co. boosted its stake in Clover Health Investments by 172.0% in the 4th quarter. JPMorgan Chase & Co. now owns 432,268 shares of the company’s stock worth $1,362,000 after purchasing an additional 273,348 shares during the period. Finally, Vanguard Group Inc. increased its position in shares of Clover Health Investments by 2.0% during the fourth quarter. Vanguard Group Inc. now owns 19,585,213 shares of the company’s stock valued at $61,693,000 after buying an additional 386,499 shares during the period. Hedge funds and other institutional investors own 19.77% of the company’s stock.

Clover Health Investments Stock Performance

Clover Health Investments stock opened at $2.90 on Thursday. Clover Health Investments, Corp. has a fifty-two week low of $1.50 and a fifty-two week high of $4.87. The stock has a market cap of $1.48 billion, a P/E ratio of -58.00 and a beta of 1.86. The firm’s fifty day moving average price is $2.98 and its 200-day moving average price is $3.55.

Clover Health Investments (NASDAQ:CLOV) last issued its quarterly earnings results on Tuesday, May 6th. The company reported $0.05 EPS for the quarter, topping analysts’ consensus estimates of ($0.07) by $0.12. The firm had revenue of $462.33 million for the quarter, compared to analyst estimates of $466.93 million. Clover Health Investments had a negative net margin of 1.69% and a negative return on equity of 7.42%. Sell-side analysts predict that Clover Health Investments, Corp. will post -0.12 earnings per share for the current year.

Insider Activity at Clover Health Investments

In other Clover Health Investments news, CEO Conrad Wai sold 118,600 shares of Clover Health Investments stock in a transaction that occurred on Tuesday, July 22nd. The stock was sold at an average price of $3.29, for a total value of $390,194.00. Following the transaction, the chief executive officer directly owned 1,494,898 shares of the company’s stock, valued at $4,918,214.42. The trade was a 7.35% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Corporate insiders own 24.07% of the company’s stock.

Clover Health Investments Company Profile

Clover Health Investments, Corp. provides medicare advantage plans in the United States. It operates through two segments: Insurance and Non-Insurance. It also offers Clover Assistant, a cloud-based software platform, that enables physicians to detect, identify, and manage chronic diseases earlier; and access to data-driven and personalized insights for the patients they treat.